IKZF1 and cancer: The disappearance of circulating methylated BCAT1 and IKZF1 DNA after tumour resection in 10 of 12 cancer cases shows that detection of methylated BCAT1 and IKZF1 DNA in the blood reflects the presence of CRC rather than a risk of developing CRC.